238 research outputs found
Near Field Communication: Technology and Market Trends
Among the different hi-tech content domains, the telecommunications industry is one of the most relevant, in particular for the Italian economy. Moreover, Near Field Communication (NFC) represents an example of innovative production and a technological introduction in the telecommunications context. It has a threefold function: card emulator, peer-to-peer communication and digital content access, and it could be pervasively integrated in many different domains, especially in the mobile payment one. The increasing attention on NFC technology from the academic community has improved an analysis on the changes and the development perspective about mobile payments. It has considered the work done by the GSMA (Global System for Mobile Communications Association) and the NFC Forum in recent years. This study starts from an analysis of the scientific contributions to Near Field Communication and how the main researches on this topic were conceived. Our focus is on the diffusion rates, the adoption rates and the technology life cycle. After that, we analyze the technical-economical elements of NFC. Finally, this work presents the state of art of the improvements to this technology with a deeper focus on NFC technologies applied to the tourism industry. In this way, we have done a case analysis that shows some of the NFC existent applications linked to each stage of the tourism value chain
Long-Term Outcomes After Surgical Versus Transcatheter Closure of Atrial Septal Defects in Adults
ObjectivesThe purpose of this study was to assess the comparative effectiveness and long-term safety of transcatheter versus surgical closure of secundum atrial septal defects (ASD) in adults.BackgroundTranscatheter ASD closure has largely replaced surgery in most industrialized countries, but long-term data comparing the 2 techniques are limited.MethodsWe performed a retrospective population-based cohort study of all patients, ages 18 to 75 years, who had surgical or transcatheter ASD closure in Québec, Canada's second-largest province, using provincial administrative databases. Primary outcomes were long-term (5-year) reintervention and all-cause mortality. Secondary outcomes were short-term (1-year) onset of congestive heart failure, stroke, or transient ischemic attack, and markers of health service use.ResultsOf the 718 ASD closures performed between 1988 and 2005, 383 were surgical and 335 were transcatheter. The long-term reintervention rate was higher in patients with transcatheter ASD closure (7.9% vs. 0.3% at 5 years, p = 0.0038), but the majority of these reinterventions occurred in the first year. Long-term mortality with the transcatheter technique was not inferior to surgical ASD closure (5.3% vs. 6.3% at 5 years, p = 1.00). Secondary outcomes were similar in the 2 groups.ConclusionsTranscatheter ASD closure is associated with a higher long-term reintervention rate and long-term mortality that is not inferior to surgery. Overall, these data support the current practice of using transcatheter ASD closure in the majority of eligible patients and support the decision to intervene on ASD with significant shunts before symptoms become evident
Promotion effect of rare earth elements (Ce, Nd, Pr) on physicochemical properties of M-Al mixed oxides (M = Cu, Ni, Co) and their catalytic activity in N2O decomposition
A series of M-AlOx mixed oxides (M = Cu, Co, Ni) with the addition of high loadings of rare earth elements (REE, R = Ce, Nd, Pr; R0.5M0.8Al0.2, molar ratio) were investigated in N2O decomposition. The precursors were prepared by coprecipitation and subsequent calcination at 600\ua0\ub0C. The obtained mixed metal oxides were characterized by X-ray diffraction with Rietveld analysis, N2 sorption, and H2 temperature-programmed reduction. Depending on the nature of REE and the initial M-Al system, R cations could be separately segregated in oxide form or coordinated with the transition metal cations and form mixed structures. The addition of Ce3+ consistently led to nanocrystalline CeO2 mixed with the divalent oxides, whereas the addition of Nd3+ or Pr3+ resulted in the formation of their respective oxide phases as well as perovskites/Ruddlesden–Popper phases. The presence of REE modified the textural and redox properties of the calcined materials. The rare earth element-induced formation of low-temperature reducible MOx species that systematically improved the N2O decomposition on the modified catalysts compared to the pristine M-Al materials by the order of Co > Ni > Cu. The Ce0.5Co0.8Al0.2 catalyst revealed the highest activity and remained stable (approximately 90% of N2O conversion) for 50\ua0h during time-on-stream in 1000\ua0ppm N2O, 200\ua0ppm NO, 20 000\ua0ppm O2, 2500\ua0ppm H2O/N2 balance at WHSV = 16 L g−1\ua0h−1
The “polonium in vivo” study. Polonium-210 in bronchial lavages of patients with suspected lung cancer
Few studies have reported on polonium-210, a decay breakdown product of radon-222 and lead-210, in human lungs and there has been no study in patients with suspected lung cancer. The main aim of this "Polonium in vivo" study was to evaluate polonium-210 radioactivity in bronchopulmonary systems of smoker, ex-smoker and never smoker patients with suspected lung cancer. Alpha-spectrometric analyses were performed on bronchial lavage (BL) fluids from two Italian hospitals in 2013-2016. Socio-demographic, smoking, occupational and spirometric characteristics, lung cancer confirmation and histologic type and radon-222 concentration in patients' homes were collected. Seventy BL samples from never (n = 13), former (n = 35) and current smokers (n = 22) were analyzed; polonium-210 was detected in all samples from current and former smokers and in 54% of samples from never smokers (p < 0.001; median values: 1.20, 1.43 and 0.40 mBq, respectively). Polonium-210 levels were significantly higher in COPD versus no COPD patients (median value: 3.60 vs. 0.97 mBq; p = 0.007); former and current smokers, without and with COPD, had significantly increased polonium-210 levels (p = 0.012); 96% of confirmed versus 69% of non-confirmed lung cancer patients recorded detectable polonium-210 levels (p = 0.018). A polonium-210 detectable activity was measured in BL samples from all current and former smokers. Polonium-210 in the lungs could be the result of lead-210 entrapment, which, with its half-life of 22 years, could provide a continuous emission of alpha radioactivity, even many years after quitting, thus proposing a possible explanation for the onset of lung cancer, particularly in former smokers
Endotracheal metastasis of hepatocellular carcinoma: a case report.
We describe the case of a 75 years old patient with a history of hepatocellular carcinoma, with acute respiratory failure due to tracheal obstruction by metastasis, successfully treated with airway disobstruction with rigid bronchoscope
Extracorporeal membrane oxygenation for COVID-19 and influenza H1N1 associated acute respiratory distress syndrome: a multicenter retrospective cohort study
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) has become an established rescue therapy for severe acute respiratory distress syndrome (ARDS) in several etiologies including influenza A H1N1 pneumonia. The benefit of receiving ECMO in coronavirus disease 2019 (COVID-19) is still uncertain. The aim of this analysis was to compare the outcome of patients who received veno-venous ECMO for COVID-19 and Influenza A H1N1 associated ARDS. METHODS: This was a multicenter retrospective cohort study including adults with ARDS, receiving ECMO for COVID-19 and influenza A H1N1 pneumonia between 2009 and 2021 in seven Italian ICU. The primary outcome was any-cause mortality at 60 days after ECMO initiation. We used a multivariable Cox model to estimate the difference in mortality accounting for patients’ characteristics and treatment factors before ECMO was started. Secondary outcomes were mortality at 90 days, ICU and hospital length of stay and ECMO associated complications. RESULTS: Data from 308 patients with COVID-19 (N = 146) and H1N1 (N = 162) associated ARDS who had received ECMO support were included. The estimated cumulative mortality at 60 days after initiating ECMO was higher in COVID-19 (46%) than H1N1 (27%) patients (hazard ratio 1.76, 95% CI 1.17–2.46). When adjusting for confounders, specifically age and hospital length of stay before ECMO support, the hazard ratio decreased to 1.39, 95% CI 0.78–2.47. ICU and hospital length of stay, duration of ECMO and invasive mechanical ventilation and ECMO-associated hemorrhagic complications were higher in COVID-19 than H1N1 patients. CONCLUSION: In patients with ARDS who received ECMO, the observed unadjusted 60-day mortality was higher in cases of COVID-19 than H1N1 pneumonia. This difference in mortality was not significant after multivariable adjustment; older age and longer hospital length of stay before ECMO emerged as important covariates that could explain the observed difference. Trial registration number: NCT05080933, retrospectively registered. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-022-03906-4
- …